MedTrace Logo

Cardiac Amyloidosis Registry of University Hospital Leipzig

NCT06129656 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-11-13

No results posted yet for this study

Summary

This is a clinical registry of patients with cardiac amyloidosis being treated at University Hospital Leipzig. The aim of the registry is to collect detailed information about clinical events, symptoms, imaging, biomarkers, comorbidities, and treatment from routine patient management which would not be provided by randomized clinical trails.

Conditions

  • Cardiac Amyloidosis

Interventions

OTHER

Routine diagnostics

Data collection of routine diagnostics

OTHER

Routine treatment

Data collection of routine treatment

Sponsors & Collaborators

  • University of Leipzig

    lead OTHER

Principal Investigators

  • Daniel Lavall, MD · University of Leipzig

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2033-05-31
Completion
2033-05-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06129656 on ClinicalTrials.gov